Tools   Select Another Resource Report Type

http://www.brandeis.edu/

Private research university located in the Boston suburb of Waltham, Massachusetts. Founded in 1948 as a non-sectarian, coeducational institution sponsored by the Jewish community, Brandeis was established on the site of the former Middlesex University.

Proper citation: Brandeis University; Massachusetts; USA (RRID:SCR_003669) Copy   

•   Source: SciCrunch Registry

http://www.ebioscience.com/

An Antibody supplier

Proper citation: eBioscience (RRID:SCR_003660) Copy   

•   Source: SciCrunch Registry

http://www.sabbiotech.com/

An Antibody supplier

Proper citation: Signalway (RRID:SCR_003659) Copy   

•   Source: SciCrunch Registry

http://genome.sph.umich.edu/wiki/RAREMETAL

A software program that facilitates the meta-analysis of rare variants from genotype arrays or sequencing.

Proper citation: RAREMETAL (RRID:SCR_003573) Copy   

•   Source: SciCrunch Registry

http://www.nitrc.org/projects/ccsegthickness

An end-to-end pipeline for corpus callosum processing that provides automated midsagittal alignment, CC segmentation with a quality control tool, and thickness profile generation. Groupwise analysis is facilitated by permutation testing with FWER and FDR multiple comparison correction. Results display is facilitated by a display script that shows p-values on a 3D pipe representation of a CC. This pipeline is implemented in MATLAB and requires the Image Processing Toolbox. There are plans to implement it completely in Python.

Proper citation: Corpus Callosum Thickness Profile Analysis Pipeline (RRID:SCR_003575) Copy   

•   Source: SciCrunch Registry

http://www.myelinrepair.org/

A non-profit foundation that funds basic research and is focused on accelerating the development of myelin repair therapeutics for multiple sclerosis. They have defined a 15-year research plan to develop a drug or drugs and believes its Accelerated Research Collaborative (ARC) model can subsequently be used to accelerate the treatment for all diseases. The ARC framework coordinates and manages the entire therapeutic development continuum from discovery biology to FDA approval. The model works by coordinating multi-disciplinary basic research from academic and government laboratories, systematically validating and derisking potential compounds/targets, and collaborating with pharma partners to increase the probability of successful programs.

Proper citation: Myelin Repair Foundation (RRID:SCR_003723) Copy   

•   Source: SciCrunch Registry

https://www.tocris.com/

An Antibody supplier

Proper citation: Tocris Bioscience (RRID:SCR_003689) Copy   

•   Source: SciCrunch Registry

http://www.transceleratebiopharmainc.com/

Non-profit research organization aiming to accelerate drug development by increasing the quality and efficiency of clinical studies through the development of shared tools, methods, and platforms. Consortium partnerships are limited to pharmaceutical and biotechnology companies with research & development operations, although there are collaborations with external organizations such the Clinical Data Interchange Standards Consortium (CDISC). Its current focus is to collaborate on: * Standardizing risk-based monitoring * Development of methods to qualify and train clinical trial sites * Development of a common investigator web portal * Development of clinical data standards on efficacy, and methods for comparator drug trials It currently has 5 projects: # Standardized Approach for High-Quality, Risk-Based Monitoring program aims to develop an industry-wide standard and approach for risk-based monitoring of clinical trials in order to enhance patient safety and ensure the quality of clinical trial data. # Shared Site Qualification and Training program aims to standardize GCP training and site qualification credentials in order to realize efficiencies and accelerate study start-up timelines. # Common Investigator Site Portal is a platform designed to streamline investigator and site access through harmonized delivery of content and services. # Data Standards project is a partnership with CDISC to develop industry-wide data standards in priority therapeutic areas to support the exchange and submission of clinical research and meta-data, improving patient safety and outcomes. # Comparator Drugs project aims to establish reliable, rapid sourcing of quality products for use in clinical trials through a comparator supply model enabling accelerated trial timelines and enhanced patient safety.

Proper citation: TransCelerate BioPharma (RRID:SCR_003728) Copy   

•   Source: SciCrunch Registry

https://www.ualg.pt/en

A young state university located in the southern part of Portugal.

Proper citation: University of Algarve; Faro; Portugal (RRID:SCR_000006) Copy   

•   Source: SciCrunch Registry

http://www.gbiosciences.com/default.aspx

Commercial antibody supplier that provides research materials for projects such as: protein purification, protein analysis, protein estimation assays, DNA purification, plasmid DNA isolation and transformation, protein quantification assays, and coupled assays for methylation. This supplier also provides buffers, reagents, education programs, and training programs.

Proper citation: G Biosciences (RRID:SCR_000007) Copy   

•   Source: SciCrunch Registry

http://dock.compbio.ucsf.edu/

An algorithm used to predict and analyse binding modes of docking molecules. Users can search ligand databases for compounds that inhibit enzymatic activity and bind to particular molecules and nucleic acid targets. Molecular docking is used to predict a predominant binding mode(s) of a ligand in three-dimensional structure. This method can be used for molecular biology and computer-assisted drug design.

Proper citation: DOCK (RRID:SCR_000128) Copy   

•   Source: SciCrunch Registry

http://www.gelifesciences.com/webapp/wcs/stores/servlet/HomeView?catalogId=10051&storeId=11787&langId=-1

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 10,2024. A commercial antibody supplier and provider of various services., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.

Proper citation: GE Healthcare (RRID:SCR_000004) Copy   

•   Source: SciCrunch Registry

http://sourceforge.net/projects/exomesuite/

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 31,2025. A software application designed to analyze variant call files from next generation sequencing data to identify variants causing disease.

Proper citation: exomeSuite (RRID:SCR_000129) Copy   

•   Source: SciCrunch Registry

https://code.google.com/p/guardd/

MATLAB software designed to organize, automate, and enhance the analytical procedures which operate on CPMG RD NMR data.

Proper citation: GUARDD (RRID:SCR_000040) Copy   

•   Source: SciCrunch Registry

http://www.bioconductor.org/packages/release/bioc/html/flowCL.html

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 31,2025. Software for semantic labelling of flow cytometric cell populations.

Proper citation: flowCL (RRID:SCR_000046) Copy   

•   Source: SciCrunch Registry

https://github.com/lskatz/cg-pipeline

A software tool for assembling genome sequence data and running feature prediction and annotation tools on the assembly.

Proper citation: CG-Pipeline (RRID:SCR_000047) Copy   

•   Source: SciCrunch Registry

https://code.google.com/p/cbrowse/

Software providing an AJAX-based web browser for visualizing and analyzing transcriptome assemblies and contigs.

Proper citation: Cbrowse (RRID:SCR_000044) Copy   

•   Source: SciCrunch Registry

http://www.imrser.org/

The Institute for Magnetic Resonance Safety, Education, and Research (IMRSER) was formed in response to the growing need for information and research on matters pertaining to magnetic resonance (MR) safety. The IMRSER is the first independent, multidisciplinary, professional organization devoted to promoting awareness, understanding, and communication of MR safety issues through education and research. Mission Statement To promote awareness and understanding of MR safety, To disseminate information regarding current and emerging MR safety issues, To develop and provide materials and resources to facilitate MR safety-related education and training, To respond to critical MR safety issues with a sense of urgency, and To advance the field of MR safety through support of scientific research. Functions and activities of the IMRSER include development of up-to-date MR safety materials and dissemination of this information to the MR community. This is accomplished predominantly through the efforts of the Advisory Boards. Members of the Advisory Boards of the Institute for Magnetic Resonance Safety, Education, and Research (IMRSER) are charged with creating recommendations, guidelines, position papers, and educational materials pertaining to existing or emerging MR safety issues. This is achieved by utilizing the pertinent peer-reviewed literature and by relying on each members extensive clinical, research, or other appropriate experience. Notably, documents developed by the IMRSER incorporate MR safety guidelines and recommendations created by the International Society for Magnetic Resonance in Medicine (ISMRM), the American College of Radiology (ACR), the Food and Drug Administration (FDA), the National Electrical Manufacturers Association (NEMA), the Medical Devices Agency (MDA), the International Electrotechnical Commission (IEC), and other similar organizations. The IMRSERs rigorous development and review process for MR safety documents ensures that authoritative and relevant information is produced in a timely manner for rapid dissemination to the MR community. The MR safety information is provided to MR healthcare professionals and others as hard copy and electronic publications. Additionally, this information is posted on the IMRSER web site as well as on www.MRIsafety.com (currently with over 92,000 registered users). The Institute for Magnetic Resonance Safety, Education, and Research permits all members of the MR community to use the MRI Safety Guidelines posted on this web site. Please be sure to read and understand our disclaimer.

Proper citation: Institute for Magnetic Resonance Safety, Education and Research (RRID:SCR_000039) Copy   

•   Source: SciCrunch Registry

http://www.bioconductor.org/packages/release/data/annotation/html/RmiR.Hs.miRNA.html

Software package for various databases of microRNA Targets.

Proper citation: RmiR.Hs.miRNA (RRID:SCR_000101) Copy   

•   Source: SciCrunch Registry

http://www.genetex.com/

An antibody supplier for the purposes of life science and biomedical research. This company has a wide variety of immunological reagents that focus on areas of research such as cancer, cell biology, epigenetics, immunology and infectious diseases.

Proper citation: GeneTex (RRID:SCR_000069) Copy   

•   Source: SciCrunch Registry